GE Healthcare's (GE -0.6%) Clarient Diagnostic Services announces the first lab developed test...

|By:, SA News Editor

GE Healthcare's (GE -0.6%) Clarient Diagnostic Services announces the first lab developed test using MultiOmyx, a new pathology platform which uses proprietary methodology to assess multiple proteins from a single tissue section at a single-cell level. This test will assist in pathologist’s diagnosis of CD30-positive lymphoma cases with difficult morphology or otherwise insufficient tissue to adequately evaluate the case.